---
title: "Five Prime Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8b7ec854-dc24-57db-95f2-7382daa885de
json: https://whiteintel.dev/api/public/dossier/8b7ec854-dc24-57db-95f2-7382daa885de
identifier: lei:549300Z652HXXGMB7V71
jurisdiction: US-DE
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Five Prime Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** US-DE  
**Identifier:** `lei:549300Z652HXXGMB7V71`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8b7ec854-dc24-57db-95f2-7382daa885de  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8b7ec854-dc24-57db-95f2-7382daa885de  

## Registry profile

- **Status:** LAPSED  
- **Legal form:** `XTIQ`  
- **Source:** GLEIF  

## Provenance

- GLEIF — https://search.gleif.org/#/record/549300Z652HXXGMB7V71

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Five Prime Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/8b7ec854-dc24-57db-95f2-7382daa885de · Structured JSON: https://whiteintel.dev/api/public/dossier/8b7ec854-dc24-57db-95f2-7382daa885de._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._